New drug improves outcome in treatment resistant kidney cancer

(Dana-Farber Cancer Institute) A new drug for renal cell carcinoma slowed the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had previously kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news